首页>Alimentary Pharmacology and Therapeutics>Commentary: Durability of SVR in chronic hepatitis C patients treated with peginterferon-A2a/ribavirin in combination with a direct-Acting anti-viral - Authors' reply
Commentary: Durability of SVR in chronic hepatitis C patients treated with peginterferon-A2a/ribavirin in combination with a direct-Acting anti-viral - Authors' reply